Frédérique Bigonzi

2.9k total citations · 1 hit paper
20 papers, 2.0k citations indexed

About

Frédérique Bigonzi is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Frédérique Bigonzi has authored 20 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 15 papers in Internal Medicine and 8 papers in Surgery. Recurrent topics in Frédérique Bigonzi's work include Acute Myocardial Infarction Research (15 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Frédérique Bigonzi is often cited by papers focused on Acute Myocardial Infarction Research (15 papers), Venous Thromboembolism Diagnosis and Management (15 papers) and Atrial Fibrillation Management and Outcomes (8 papers). Frédérique Bigonzi collaborates with scholars based in United States, France and United Kingdom. Frédérique Bigonzi's co-authors include Keith A.A. Fox, Enrique Gurfinkel, Gregg Fromell, Alexander G.G. Turpie, Anatoly Langer, Christine Demers, Robert M. Califf, Jerôme Premmereur, Shaun Goodman and Beth Davison Weatherley and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Frédérique Bigonzi

19 papers receiving 1.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease

1997 1.0k citations Marc J. Cohen, Christine Demers et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Frédérique Bigonzi	1.8k	970	741	413	105	20	2.0k
Jerôme Premmereur	2.1k 1.2×	1.1k 1.2×	889 1.2×	562 1.4×	82 0.8×	9	2.2k
Alexander G. G. Turpie	1.3k 0.7×	717 0.7×	404 0.5×	237 0.6×	68 0.6×	17	1.5k
Patrick Coussement	843 0.5×	221 0.2×	496 0.7×	278 0.7×	61 0.6×	40	1.0k
Brent McLaurin	1.3k 0.7×	345 0.4×	974 1.3×	342 0.8×	27 0.3×	24	1.5k
Steven P. Ball	572 0.3×	252 0.3×	304 0.4×	111 0.3×	113 1.1×	27	814
Pekka Porela	1.0k 0.6×	143 0.1×	343 0.5×	243 0.6×	79 0.8×	41	1.3k
Debbie Robertson	1.4k 0.8×	153 0.2×	823 1.1×	753 1.8×	59 0.6×	8	1.7k
Russell Raymond	897 0.5×	168 0.2×	798 1.1×	409 1.0×	51 0.5×	49	1.3k
Pieter J. Vlaar	1.8k 1.0×	331 0.3×	1.3k 1.8×	920 2.2×	10 0.1×	36	1.9k
Thomas Shimshak	1.2k 0.7×	159 0.2×	1.1k 1.5×	557 1.3×	21 0.2×	54	1.5k

Countries citing papers authored by Frédérique Bigonzi

Since Specialization

Citations

This map shows the geographic impact of Frédérique Bigonzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédérique Bigonzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédérique Bigonzi more than expected).

Fields of papers citing papers by Frédérique Bigonzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédérique Bigonzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédérique Bigonzi. The network helps show where Frédérique Bigonzi may publish in the future.

Co-authorship network of co-authors of Frédérique Bigonzi

This figure shows the co-authorship network connecting the top 25 collaborators of Frédérique Bigonzi. A scholar is included among the top collaborators of Frédérique Bigonzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédérique Bigonzi. Frédérique Bigonzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martin, Jack L., et al.. (2004). Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study. Catheterization and Cardiovascular Interventions. 61(2). 163–170. 54 indexed citations

Cohen, Marc, Gian Franco Gensini, Frans Maritz, et al.. (2003). The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI). Journal of the American College of Cardiology. 42(8). 1348–1356. 48 indexed citations

Fox, Keith A.A., Elliott M. Antman, Marc Cohen, & Frédérique Bigonzi. (2002). Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non–ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention. The American Journal of Cardiology. 90(5). 477–482. 34 indexed citations

Cohen, Marc, Pierre Théroux, Steven Borzak, et al.. (2002). Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: The ACUTE II study. American Heart Journal. 144(3). 470–477. 103 indexed citations

Antman, Elliott M., Hans W. Louwerenburg, Hubert F. Baars, et al.. (2002). Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction. Circulation. 105(14). 1642–1649. 156 indexed citations

Antman, EM, et al.. (2001). Enoxaparin with or without GPIIb/IIIa inhibition as reperfusion strategy in ST-segment elevation MI - results of the ENTIRE-TIMI 23 trial. European Heart Journal. 22. 15–15. 1 indexed citations

Berkowitz, Scott D., Sandra S. Stinnett, Marc Cohen, Gregg Fromell, & Frédérique Bigonzi. (2001). Prospective comparison of hemorrhagic complications after treatment with enoxaparin versus unfractionated heparin for unstable angina pectoris or non–ST-segment elevation acute myocardial infarction. The American Journal of Cardiology. 88(11). 1230–1234. 25 indexed citations

Ross, Allan M., Peter Molhoek, Conor F. Lundergan, et al.. (2001). Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin. Circulation. 104(6). 648–652. 102 indexed citations

Goodman, Shaun G., Mauricio G. Cohen, & Frédérique Bigonzi. (2001). Randomized trial of low molecular weight heparin (enoxaparin) vs. unfractionated heparin for unstable coronary artery disease: 1-year results of the ESSENCE study. ACC Current Journal Review. 10(1). 15–15.

10.

Goodman, Shaun G., Marc Cohen, Frédérique Bigonzi, et al.. (2000). Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.. Journal of the American College of Cardiology. 36(3). 693–698. 105 indexed citations

11.

Cohen, Marc, Elliott M. Antman, Enrique Gurfinkel, et al.. (2000). Impact of enoxaparin low molecular weight heparin in patients with Q-wave myocardial infarction. The American Journal of Cardiology. 86(5). 553–556. 9 indexed citations

12.

Cohen, Marc, Frans Maritz, Gian Franco Gensini, et al.. (2000). The TETAMI Trial: The Safety and Efficacy of Subcutaneous Enoxaparin versus Intravenous Unfractionated Heparin and of Tirofiban versus Placebo in the Treatment of Acute Myocardial Infarction for Patients Not Thrombolyzed: Methods and Design. Journal of Thrombosis and Thrombolysis. 10(3). 241–246. 21 indexed citations

13.

Cohen, Marc, Christine Demers, Enrique Gurfinkel, et al.. (1998). Low-molecular-weight heparins in non–ST-segment elevation ischemia: the ESSENCE trial. The American Journal of Cardiology. 82(5). 19L–24L. 68 indexed citations

14.

Cohen, Mauricio G., et al.. (1998). One year follow-up of the ESSENCE trial (enoxaparin versus heparin in unstable angina and non-Q-wave myocardial infarction). Journal of the American College of Cardiology. 31. 79–79. 7 indexed citations

15.

Montalescot, Gilles, Philippe François, Annick Ankri, et al.. (1998). Early Increase of von Willebrand Factor Predicts Adverse Outcome in Unstable Coronary Artery Disease. Circulation. 98(4). 294–299. 209 indexed citations

16.

Cohen, Marc J., Christine Demers, Enrique Gurfinkel, et al.. (1997). A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease. New England Journal of Medicine. 337(7). 447–452. 1004 indexed citations breakdown →

17.

Juillière, Yves, Nicolas Danchin, Michel E. Bertrand, et al.. (1993). Cardioprotective effect of intracoronary nifedipine during percutaneous transluminal coronary angioplasty. A French double-blind cross-over multicentre study. International Journal of Cardiology. 39(1). 43–48. 2 indexed citations

18.

Lascault, G, Frédérique Bigonzi, R Frank, et al.. (1989). Non-invasive study of dual chamber pacing by pulsed Doppler. Prediction of the haemodynamic response by echocardiographic measurements. European Heart Journal. 10(6). 525–531. 9 indexed citations

19.

Bigonzi, Frédérique, et al.. (1988). [Use of molar lactate in intracavitary electrophysiological study of a ventricular tachycardia].. PubMed. 17(6). 284–284. 2 indexed citations

20.

Bigonzi, Frédérique, et al.. (1987). [Isolated pulmonary lymphoma in a patient with acquired immunodeficiency syndrome].. PubMed. 43(4). 216–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact